Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 15;14(8):2716.
doi: 10.3390/jcm14082716.

Narrative Review on Common Traits of Parkinson's Disease and Epilepsy

Affiliations
Review

Narrative Review on Common Traits of Parkinson's Disease and Epilepsy

Christian Tilz et al. J Clin Med. .

Abstract

Epilepsy and Parkinson's disease (PD) are two common neurological disorders, with a lifetime prevalence of approximately 1% and 0.4%, respectively. Both conditions affect movement and brain function and were traditionally considered distinct, with different pathophysiological mechanisms. However, recent research suggests potential links between them. Some studies indicate that epilepsy may contribute to the development of PD due to chronic neuroinflammation, excitotoxicity, and neuronal loss. Conversely, PD-related neurodegeneration in dopaminergic pathways might increase susceptibility to seizures. This article presents a narrative review of the limited literature on the pathophysiological mechanisms linking epilepsy and PD, including shared genetic factors, neurodegenerative processes, and alterations in the neurotransmitter system. It also examines the influence of anti-seizure medications and dopaminergic treatments on the symptoms and progression of both disorders, as well as their common clinical features. Additionally, the limitations of the existing data on this topic are discussed. Understanding the true relationship between these two disorders is crucial, as it could provide insight into common neurobiological mechanisms and lead to improved therapeutic strategies.

Keywords: Parkinson’s disease; antiseizure medication (ASM); epilepsy; genetics; neurostimulation.

PubMed Disclaimer

Conflict of interest statement

C. Tilz received honoraria from Angelini Pharma, Eisai, UCB. Y. Wang-Tilz received a congress invitation from Angelini Pharma, Eisai, UCB.

References

    1. Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E., Engel J., Jr., Forsgren L., French J.A., Glynn M., et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia. 2014;55:475–482. doi: 10.1111/epi.12550. - DOI - PubMed
    1. Höglinger G.U., Adler C.H., Berg D., Klein C., Outeiro T.F., Poewe W., Postuma R., Stoessl A.J., Lang A.E. A biological classification of Parkinson’s disease: The SynNeurGe research diagnostic criteria. Lancet Neurol. 2024;23:191–204. doi: 10.1016/S1474-4422(23)00404-0. Erratum in Lancet Neurol. 2024, 23, e7. - DOI - PubMed
    1. Peljto A.L., Barker-Cummings C., Vasoli V.M., Leibson C.L., Hauser W.A., Buchhalter J.R., Ottman R. Familial risk of epilepsy: A population-based study. Pt 3Brain. 2014;137:795–805. doi: 10.1093/brain/awt368. - DOI - PMC - PubMed
    1. Ebrahimi-Fakhari D., Kang K.-S., Kotzaeridou U., Kohlhase J., Klein C., Assmann B.E. Child Neurology: PRRT2-associated movement disorders and differential diagnoses. Neurology. 2014;83:1680–1683. doi: 10.1212/WNL.0000000000000936. Erratum in Neurology 2015, 84, 105. - DOI - PubMed
    1. Sillanpää M., Kälviäinen R., Klaukka T., Helenius H., Shinnar S. Temporalchanges in the incidence of epilepsy in Finland: Nationwide study. Epilepsy Res. 2006;71:206–215. doi: 10.1016/j.eplepsyres.2006.06.017. - DOI - PubMed

LinkOut - more resources